AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

TransCode Therapeutics, Inc.

$1.63 -$5.77 (-77.97%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$1.73
Day Range
$1.62$1.78
Year Range
$1.52$12.60
Market Cap
1.73M
AVG Volume
46.56K
Trailing/Forward PE
-0.03/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-18
Primary Exchange
NASDAQUS
Net Income (USD) · A
-40M-30M-20M-10M0202020212022202320242025
RNAZ Net Income (USD) by year
PeriodNet Income (USD)
2025-34.66M
2024-16.75M
2023-18.55M
2022-17.56M
2021-6.84M
2020-2.34M
Operating Income (USD) · A
-30M-20M-10M0202020212022202320242025
RNAZ Operating Income (USD) by year
PeriodOperating Income (USD)
2025-27.98M
2024-15.66M
2023-19.42M
2022-18.67M
2021-6.15M
2020-726.6K
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: RNAZ

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 18 Nov 2026.

TransCode Therapeutics, Inc.
RNAZ
Stockpicker

Video analysis: RNAZ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: RNAZ

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.